Lv1
30 积分 2025-12-23 加入
Novel Dual and Triple Agonists Targeting GLP-1, GIP, Glucagon, and GDF15 for Type 2 Diabetes and Obesity Management
12小时前
待确认
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
13小时前
已完结
AI-driven protein design
4天前
已完结
The mitochondrial integrated stress response: A novel approach to anti-aging and pro-longevity
7天前
已完结
The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic
8天前
已完结
GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
8天前
已完结
Metabolic Messenger: growth differentiation factor 15
8天前
已完结
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease
8天前
已完结
Obesity in China: current progress and future prospects
9天前
已完结
GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand
19天前
已完结
皖公网安备34019202002308
